Sheahan K, Shuja S, Murnane M J
Mallory Institute of Pathology, Boston University School of Medicine, Massachusetts 02118.
Cancer Res. 1989 Jul 15;49(14):3809-14.
Many studies of malignant cells or tissues in culture have implicated cysteine proteases in the progression of malignancy. We have extended these observations by measuring quantitative and qualitative changes in the expression of cathepsin B-like and L-like cysteine proteases during the growth and development of human colorectal carcinomas. Data derived from matched pairs of normal colorectal mucosa and carcinoma tissue from 27 patients demonstrated that both cathepsin B-like and cathepsin L-like specific activities were significantly elevated (P less than 0.005) in the carcinoma tissue, while levels of endogenous cysteine protease inhibitor remained constant. Correlation of cathepsin enzyme activities with different stages of colorectal cancer demonstrated significantly higher cysteine protease activities in individuals with Dukes' A tumors (tumors confined to the bowel wall) than in patients with more advanced tumors (Dukes' B, C, or D tumors) (P less than 0.01-0.05). The relative proportion of activities contained in tumor epithelial and stromal elements remains to be elucidated. These results suggest an important role for cysteine proteases in the early progression of human colorectal carcinoma.
许多对培养中的恶性细胞或组织进行的研究表明,半胱氨酸蛋白酶与恶性肿瘤的进展有关。我们通过测量人结肠直肠癌生长和发展过程中组织蛋白酶B样和L样半胱氨酸蛋白酶表达的定量和定性变化,扩展了这些观察结果。来自27例患者的配对正常结肠直肠黏膜和癌组织的数据表明,癌组织中组织蛋白酶B样和组织蛋白酶L样的比活性均显著升高(P小于0.005),而内源性半胱氨酸蛋白酶抑制剂的水平保持不变。组织蛋白酶活性与结肠癌不同阶段的相关性表明,患有Dukes'A期肿瘤(肿瘤局限于肠壁)的个体的半胱氨酸蛋白酶活性显著高于患有更晚期肿瘤(Dukes'B、C或D期肿瘤)的患者(P小于0.01 - 0.05)。肿瘤上皮和基质成分中活性的相对比例仍有待阐明。这些结果表明半胱氨酸蛋白酶在人结肠直肠癌的早期进展中起重要作用。